The Medicine Safety Improvement Programme (MedSIP), commissioned by NHS England and NHS Improvement as part of the Patient Safety Strategy, is in its third year. It aims to reduce severe avoidable medication related harm by 50% by 2024 (World Health Organisation Third Global Patient Safety Challenge).
Project overview
The programme has one primary objective:
We are working with Hampshire and Isle of Wight Integrated Care System (ICS) with representatives from Dorset locality to define, develop, deliver, and measure a whole system programme which improves the care required to assist with people to ‘live well with pain’.
The work will be underpinned by the principles of quality improvement, co-design and patient safety learning. The Opioid Medicines Patient Safety Network has been established to develop and implement the chosen interventions to improve care in Wessex.
The driver diagram below highlights the aims and priorities of the programme for 2024/25.
The Opioid Prescribing Comparators Dashboard
In April 2021, Wessex commenced working with a group of local clinicians, and statisticians and data analysts from the NHSBSA to develop a small number of prescribing comparators to;
The comparators that will be available are:
In October 2022, a second publication of the dashboard was released, using validated primary care prescribing data in ePACT2. It enables GP practices, PCNs, ICBs, NHS Regions and HINs to review trend data over time to see the impact of activities in this complex area of reducing harm from opioid prescribing.
If you are interested in learning more about the programme and the work we are doing, please do not hesitate to contact the Programme Manager by the link below.
If you are interested in our other work relating to medicines, please visit the Health Innovation Wessex's Medicines Optimisation page
